Simplify Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Buy
14,190
+3,407
+32% +$413K 0.02% 70
2026
Q1
$1.76M Sell
10,783
-26,107
-71% -$4.01M 0.03% 58
2025
Q4
$6.42M Buy
36,890
+17,226
+88% +$3.14M 0.1% 30
2025
Q3
$2.83M Buy
19,664
+4,128
+27% +$506K 0.05% 41
2025
Q2
$1.56M Sell
15,536
-5,094
-25% -$389K 0.08% 46
2025
Q1
$1.57M Buy
20,630
+110
+0.5% +$8.41K 0.06% 56
2024
Q4
$1.42M Buy
+20,520
New +$1.48M 0.07% 60
2024
Q3
Sell
-20,788
Closed -$1.39M 114
2024
Q2
$1.39M Buy
+20,788
New +$806K 0.09% 59

Other funds holding INSM

Simplify Asset Management's INSM Position: Q2 2026 in Review

Simplify Asset Management increased its Insmed (INSM) stake by 32% in Q2 2026, buying an estimated $413K and bringing the position to 14,190 shares worth $1.51M. The position accounts for 0.02% of the portfolio, ranked #70.

Simplify Asset Management first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.42M in Q4 2025. 63 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Simplify Asset Management held 14,190 shares of Insmed worth $1.51M as of Q2 2026.
  • Simplify Asset Management bought 3,407 Insmed shares in Q2 2026, an estimated $413K.
  • Insmed made up 0.02% of Simplify Asset Management's portfolio in Q2 2026, its #70 holding.
  • Simplify Asset Management first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • Simplify Asset Management's Insmed position peaked at $6.42M in Q4 2025.
  • 63 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.